HYPOGLYCEMIC EFFECTS OF BARLERIA NOCTIFLORA FRACTIONS ON HIGH FAT FED WITH LOW DOSE STREPTOZOTOCIN INDUCED TYPE-2 DIABETES IN RATS

  • Suresh Arumugam Department of Pharmacology, Department of Pharmaceutical chemistry, JKKMMRF College of Pharmacy, Ethirmedu, B. Komarapalayam, Namakkal 638183. Tamilnadu, India
  • Senthilkumar Natesan JKKMMRF College of Pharmacy, Ethirmedu, B. Komarapalayam, Namakka

Abstract

Objective: To investigate in vitro and in vivo antidiabetic activity of Barleria noctiflora (B. noctiflora) fractions on high-fat diet (HFD) with low dose Streptozotocin (STZ) induced type-2 diabetes in rats.

Methods: B. noctiflora were successively extracted and then fractionated by Ethyl acetate and n. butanol. The in vitro antidiabetic activity from α-amylase and α-glucosidase was used to evaluate the potential activity of the fractions. The in vivo antidiabetic activity is evaluated against HFD/STZ induced type-2 diabetic in rats at a dose of 100 mg/kg, 200 mg/kg and 400 mg/kg, p. o for 28days.

Results: Ethyl acetate fraction of B. noctiflora (EAFBN) showed the highest antidiabetic activity and IC50 values of α-amylase inhibition (114.7±0.15) and α-glucosidase inhibition (104.93±0.28) than other fraction. In HFD/STZ (40 mg/kg) diabetic rats the EAFBN showed a dose dependent significant hypoglycemic property from body weight, blood glucose, serum lipids, serum cholesterol, serum triglycerides, urea, creatinine, hepatic enzymes and liver glycogen levels. The EAFBN significantly (P<0.01) increase the level of serum insulin. Histologically, focal necrosis was observed in the diabetic rat pancreas; however, was less obvious in treated groups.

Conclusion: The EAFBN is a potent hypoglycemic agent and beneficial in reducing the elevated blood glucose level, improve the lipid profile and insulin level and histopathological changes in the pancreas of HFD/STZâ€induced nonâ€genetic rat model of type-2 diabetes mellitus.

Keywords: Antidiabetic, Barleria noctiflora, Streptozotocin, Type-2 diabetes

Downloads

Download data is not yet available.

References

1. American diabetes association diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31:S55–60.
2. International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels; 2011.
3. Jing M, Rayner CK, Jones KL, Horowitz Z. Insulin secretion in healthy subjects and patients with type 2 diabetes role of the gastrointestinal tract. Best Pract Res Clin Endocrinol Metab 2009;23:413–24.
4. Maarel MJEC, Veen B, Uitdehaag JCM, Leemhuis H, Dijkhuizen L. Properties and applications of starch-converting enzymes of the α-amylase family. J Biotechnol 2002;94:137–55.
5. Goodman and Gillman. The pharmacological basis of therapeutics. 12th ed. New York: McGrawHill Medical Publishing Division; 2011. p. 1237–74.
6. Sos skovso. Modeling type 2 diabetes in rats using high-fat diet and streptozotocin. J Diabetic Investigation 2014;5:349-58.
7. De Smet PAGM. Health risk of herbal remedies. Drug Safety 1995;13:81-93.
8. Cardellina JH. Challenges and opportunities confronting the botanical dietary supplement industry. J Nat Prod 2002;65:1073-84.
9. Athar A, Kosmulalage S, Kalhari, Radhika S. Chemical constituents of Barleria prionitis and their enzyme inhibitors and free radical scavenging activities. Phytochem Lett 2009;2:37-40.
10. Madhu V, Chinnaiah B, Swamy TN. Traditional herbal remedies to cure asthma in Adilabad District. Int J Pharm Life Sci 2010;1:217-21.
11. Amala Sowmyananth. Traditional medicines for modern times, Antidiabetic plants. Plants used in the treatment of diabetes. Boca raton: CRC press; 2006. p. 49.
12. Jarald EE, Joshi SB, Jain DC, S Edwin S. Biochemical evaluation of the hypoglycemic effects of an extract of Cassia fistula Linn. In Alloxan-induced diabetic rats. Indian J Pharm Sci 2013;75:427–34.
13. Rao TN, Kumarappan C, Thilagam E, Mohanalakshmi S, Subash MC. Inhibition of carbohydrate digestive enzymes by Talinum portulacifolium (Forssk) leaf extract. J Complementary Integr Med 2008;5:1–10.
14. Subramanian R, Asmawi MZ, Sadikun A. In vitro α-glucosidase and α-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide. Acta Biochim Pol 2008;55:391–8.
15. PHS. Public health service policy on human health care and use of laboratory animals. Washington D.C: U.S department of health and human services; 2015.
16. Gandhi GR, Stalin A, Balakrishna K. Insulin sensitization via partial agonism of PPARgamma and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in type 2 diabetic rats. Biochim Biophys Acta 2013;1830:2243–55.
17. Prem Kumar N, Annamalai AR, Thakur RS. Antinociceptive property of Emblica officinalis Gaertn (Amla) in high-fat diet fed/low dose streptozotocin-induced diabetic neuropathy in rats. Indian J Exp Biol 2009;47:737-42.
18. Carroll VV, Longly RW, Joseph HR. Determination of glycogen in liver and muscle by use of anthrone reagent. J Biol Chem 1956;220:583-93.
19. Nafisa PCF, Chakradhar VL, Vandana SP, Suresh RN. An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC Complementary Altern Med 2007;29:1-8.
20. Sivashanmugam AT, Tapan Kumar C. In vitro and in vivo antidiabetic activity of Polyalthia longifolia (Sonner.) Leaves. Orient Pharm Exp Med 2013;13:289–300.
21. Suvarchala Reddy NVL, Sneha JA, Raghavendra NM. In vitro antioxidant and antidiabetic activity of Asystasia gangetica (Chinese Violet) Linn. (Acanthaceae). Int J Res Pharm Biomed Sci 2010;1:72-5.
22. Pushparaj PN, Low HK, Manikandan J, Tan BK, Tan CH. Antidiabetic effects of Cichorium intybus in streptozotocin-induced diabetic rats. J Ethnopharmacol 2007;111:430–4.
23. Girija K, Kuruba L, Nagaraj P, Pulla UC. Antihyperglycemic and hypolipidemic activity of methonalic extract of Amaranthus viridus leaves in experimental diabetics. Indian J Pharmacol 2011;43:450-4.
24. Murali B, Upadhyaya UM, Goyal RK. Effect of chronic treatment with Enicostemma littorale in non-insulin dependent diabetic (NIDDM) rats. J Ethnopharmacol 2002;81:199-204.
25. Harris EH. Elevated liver function tests in type 2 diabetes. Clin Diabetes 2005;23:115–9.
26. Erejuwa OO, Sulaiman SA, Wahab MS, Sirajudeen KNS, Salleh MS, Gurtu S. Hepatoprotective effect of tualang honey supplementation in streptozotocin-induced diabetic rats. Int J Appl Res Nat Prod 2012;4:37–41.
27. Somani R, Kasture S, Singhai AK. Antidiabetic potential of Butea monosperma in rats. Fitoterapia 2006;77:86‐90.
28. Sathishsekar D, Subramanian S. Beneficial effects of Momordica charantia seeds in the treatment of STZ‐induced diabetes in experimental rats. Biol Pharm Bull 2005;28:978–83.
29. Szkudelski T. The mechanism of alloxan and streptozotocin action β cells of the rat pancreas. Physiol Res 2001;50:536-46.
30. Yazdanparast R, Esmaeili MA, Helan JA. Teucrium polium extract effects pancreatic function of streptozotocin diabetic rats: a histopathological examination. Iran Biomed J 2005;9:81–5.
Statistics
236 Views | 648 Downloads
How to Cite
Arumugam, S., and S. Natesan. “HYPOGLYCEMIC EFFECTS OF BARLERIA NOCTIFLORA FRACTIONS ON HIGH FAT FED WITH LOW DOSE STREPTOZOTOCIN INDUCED TYPE-2 DIABETES IN RATS”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8, no. 2, Feb. 2016, pp. 193-00, https://innovareacademics.in/journals/index.php/ijpps/article/view/9931.
Section
Original Article(s)